Wu Wenming
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer (NCT06353646) | Wu Wenming | 2024-03-12 |
Track Wu Wenming automatically
Every clearance here is in the API, with alerts when new ones post.